Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
Published on: May 31, 2024
Development and validation of a risk scoring model for postoperative adult moyamoya disease
Moinay Kim1, Wonhyoung Park1, Yeongu Chung2
11Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
Objective:
The current grading system for moyamoya disease (MMD) is focused on angiographic studies with limited clinical application. The authors aimed to determine relevant factors that may impact postoperative outcome and establish a scoring system to predict the functional outcome.
Methods:
Adult patients with MMD who underwent treatment between 1998 and 2016 were included. Factors such as age, sex, comorbidity, smoking, MMD family history, initial presentation, multimodal imaging modalities, and types of surgical revascularization were thoroughly reviewed. These factors were analyzed to determine possible risk factors related to unfavorable 6-month postoperative outcomes using the modified Rankin Scale (mRS) (unfavorable: mRS score ≥ 3). A scoring system was developed using these independent risk factors to predict the outcome and validated using prospectively collected data from multiple centers between 2017 and 2018.
Results:
Of 302 patients for whom applications were submitted, 260 patients (321 hemispheres) met the diagnostic criteria. In multivariate analysis, hyperlipidemia, smoking, cerebral infarction on preoperative CT or MRI, and moderately to severely reduced regional cerebrovascular reserve results from Diamox SPECT were significantly related to unfavorable outcome. The authors developed a scoring system and stratified patients into risk groups according to their scores: low-risk (score 0-3), intermediate-risk (score 4-6), and high-risk (score 7-9) groups. This model demonstrated both good discrimination and calibration using C-statistics and the Hosmer-Lemeshow goodness-of-fit test showing 0.812 (95% CI 0.743-0.881) (p = 0.568) for the development and 0.954 (95% CI 0.896-1) (p = 0.097) for the temporal and external validation cohort.
Conclusions:
The authors' scoring system is readily adoptable to predict the postoperative outcome for MMD. Their data revealed the importance of smoking and hyperlipidemia, which were the only modifiable factors included in the scoring system. The authors validated their scoring system both internally and externally and maintained good performance, highlighting the system's generalizability and reliability.
Insights
A new scoring system predicts moyamoya disease (MMD) postoperative outcomes, identifying smoking and hyperlipidemia as key modifiable risk factors. This tool aids in assessing patient prognosis and guiding treatment strategies for better functional recovery.
Area of Science:
- Neurology
- Neurosurgery
- Radiology
Background:
- The current grading system for moyamoya disease (MMD) relies heavily on angiographic findings, offering limited clinical utility for predicting patient outcomes.
- There is a need for a clinically applicable scoring system to forecast functional recovery after MMD treatment.
Purpose of the Study:
- To identify factors influencing postoperative outcomes in adult moyamoya disease patients.
- To develop and validate a predictive scoring system for functional outcomes in MMD.
Main Methods:
- Retrospective analysis of adult MMD patients (1998-2016) examining factors like age, comorbidities, smoking, imaging, and surgical techniques.
- Multivariate analysis identified risk factors for unfavorable 6-month outcomes (modified Rankin Scale score ≥ 3).
- A scoring system was developed and validated using prospective, multi-center data (2017-2018).
Main Results:
- Hyperlipidemia, smoking, preoperative cerebral infarction (CT/MRI), and reduced regional cerebrovascular reserve (Diamox SPECT) were significant predictors of unfavorable outcomes.
- A scoring system stratified patients into low-risk (0-3), intermediate-risk (4-6), and high-risk (7-9) groups.
- The model demonstrated strong predictive performance with C-statistics of 0.812 (development) and 0.954 (validation).
Conclusions:
- The developed scoring system is practical for predicting MMD postoperative outcomes.
- Smoking and hyperlipidemia, the only modifiable factors, are crucial for risk assessment.
- Internal and external validation confirmed the scoring system's generalizability and reliability.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Valve Prolapse II: Assessment and Management

